A. M. Gammazza, “Doxorubicin anti-tumor mechanisms include Hsp60 post-translational modifications leading to the Hsp60/p53 complex dissociation and instauration of replicative senescence”, Ital J Anat Embryol, vol. 121, no. 1, p. 131, Oct. 2017.